DEF 14A

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 21, 2015

Period of Report

June 12, 2015

Accession Number

0001047469-15-003736

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →